[1]
|
European Centre for Disease Prevention and Control (2018) Infographic: HIV Late Diagnosis: 2017 Data.
https://www.ecdc.europa.eu/en/publications-data/ infographic-hiv-late-diagnosis-2017-data
|
[2]
|
HIV.gov (2019) Too Many People Living with HIV in the U.S. Don’t Know It.
https://www.hiv.gov/blog/too-many-people-living-hiv-us-don-t-know-it?utm_source=email&utm_medium=email&utm_campaign=weekly20190614
|
[3]
|
Spudich, S., Robertson, K.R., Bosch, R.J., et al. (2019) Persistent HIV-Infected Cells in Cerebrospinal Fluid Are Associated with Poorer Neurocognitive Performance. Journal of Clinical Investigation, 129, 3339-3346. https://doi.org/10.1172/JCI127413
|
[4]
|
Beck, A., McNally, I. and Petrak, J. (2003) Psychosocial Predictors of HIV/STI Risk Behaviors in a Sample of Homosexual Men. Sexually Transmitted Infections, 79, 142-146. https://doi.org/10.1136/sti.79.2.142
|
[5]
|
Rotheram-Borus, M.J., Swendeman, D. and Chovnick, G. (2009) The Past, Present, and Future of HIV Prevention: Integrating Behavioral, Biomedical, and Structural Intervention Strategies for the Next Generation of HIV Prevention. Annual Review Clinical Psychology, 5, 143-167.
https://doi.org/10.1146/annurev.clinpsy.032408.153530
|
[6]
|
Bayer, R. and Fairchild, A.L. (2006) Changing the Paradigm for HIV Testing—The End of Exceptionalism. The New England Journal of Medicine, 355, 647-649.
https://doi.org/10.1056/NEJMp068153
|
[7]
|
UNAIDS (2019) Global AIDS Update 2019—Communities at the Centre.
https://www.unaids.org/sites/default/files/media_asset/2019-global-AIDS-update_en.pdf
|
[8]
|
European Centre for Disease Prevention and Control, WHO Regional Office for Europe (2019) HIV/AIDS Surveillance in Europe 2019-2018 Data. ECDC, Stockholm.
https://www.ecdc.europa.eu/sites/default/files/documents/ HIV-annual-surveillance-report-2019.pdf
http://ECDC-WHO-HIV-surveillance-report-2018-data.pptx
|
[9]
|
World Health Organization (WHO) (2011) Global Health Sector Strategy on HIV/AIDS 2011-2015.
http://whqlibdoc.who.int/publications/2011/9789241501651_eng.pdf
|
[10]
|
Johnson, W.D., Diaz, R.M., Flanders, W.D., et al. (2008) Behavioral Interventions to Reduce Risk for Sexual Transmission of HIV among Men Who Have Sex with Men. Cochrane Database of Systematic Reviews, 16, CD001230.
https://doi.org/10.1002/14651858.CD001230.pub2
|
[11]
|
Crepaz, N., Marks, G., Liau, A., et al. (2009) Prevalence of Unprotected Anal Intercourse among HIV-Diagnosed MSM in the United States: A Meta-Analysis. AIDS, 23, 1617-1629. https://doi.org/10.1097/QAD.0b013e32832effae
|
[12]
|
Bengtsson, L. and Thorson, A. (2010) Global HIV Surveillance among MSM: Is Risk Behavior Seriously Underestimated? AIDS, 24, 2301-2303.
https://doi.org/10.1097/QAD.0b013e32833d207d
|
[13]
|
McDaid, L.M. and Hart, G. (2010) Sexual Risk Behaviour for Transmission of HIV in Men Who Have Sex with Men: Recent Findings and Potential Interventions. Current Opinion in HIV and AIDS, 5, 311-315.
https://doi.org/10.1097/COH.0b013e32833a0b86
|
[14]
|
Fenton, K. (2013) The Resurgent Global HIV Epidemic in Men Who Have Sex with Men (MSM). Plenary Lecture, BHIVA Autumn Conference.
https://www.bhiva.org/file/zkSwsEmuaKOje/KevinFenton.pdf
|
[15]
|
Hess, K.L., Crepaz, N., Rose, C., Purcell, D. and Paz-Bailey, G. (2017) Trends in Sexual Behavior among Men Who Have Sex with Men (MSM) in High-Income Countries, 1990-2013: A Systematic Review. AIDS and Behavior, 21, 2811-2834.
https://doi.org/10.1007/s10461-017-1799-1
|
[16]
|
Hué, S., Brown, A.E., Ragonnet-Cronin, M., Lycett, S.J., Dunn, D.T., Fearnhill, E., Dolling, D.I., Pozniak, A., Pillay, D., Delpech, V.C., Leigh Brown, A.J. and UK Collaboration on HIV Drug Resistance and the Collaborative HIV, Anti-HIV Drug Resistance Network (CHAIN) (2014) Phylogenetic Analyses Reveal HIV-1 Infections between Men Misclassified as Heterosexual Transmissions. AIDS, 28, 1967-1975.
https://doi.org/10.1097/QAD.0000000000000383
|
[17]
|
Schrimshaw, E.W., Downing, M.J. and Cohn, D.J. (2018) Reasons for Non-Disclosure of Sexual Orientation among Behaviorally Bisexual Men: Non-Disclosure as Stigma Management. Archives of Sexual Behavior, 47, 219-233.
https://doi.org/10.1007/s10508-016-0762-y
|
[18]
|
Ragonnet-Cronin, M., Hu, Y.W., Morris, S.R., Sheng, Z., Poortinga, K. and Wertheim, J.O. (2019) HIV Transmission Networks among Transgender Women in Los Angeles County, CA, USA: A Phylogenetic Analysis of Surveillance Data. Lancet HIV, 6, e164-e172. https://doi.org/10.1016/S2352-3018(18)30359-X
|
[19]
|
European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2008) HIV/AIDS Surveillance in Europe 2007. European Centre for Disease Prevention and Control, Stockholm.
https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/ 0812_SUR_HIV_AIDS_surveillance_in_Europe.pdf
|
[20]
|
HIV.gov, Centers for Disease Control and Prevention, USA (2019) Source: CDC, HIV Incidence: Estimated Annual Infections in the U.S., 2010-2016. U.S. Statistics, Fast Facts. https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics
|
[21]
|
Crepaz, N., Hess, K.L., Purcell, W. and Hall, H.I. (2019) Estimating National Rates of HIV Infection among MSM, Persons Who Inject Drugs, and Heterosexuals in the United States. AIDS, 33, 701-708. https://doi.org/10.1097/QAD.0000000000002111
|
[22]
|
Beyrer, C., Sullivan, P., Sanchez, J., Baral, S.D., Collins, C., Wirtz, A.L., Altman, D., Trapence, G. and Mayer, K. (2013) The Increase in Global HIV Epidemics in MSM. AIDS, 27, 2665-2678. https://doi.org/10.1097/01.aids.0000432449.30239.fe
|
[23]
|
European Centre for Disease Prevention and Control, WHO Regional Office for Europe (2018) HIV/AIDS Surveillance in Europe 2018-2017 Data. WHO Regional Office for Europe, Copenhagen.
https://www.ecdc.europa.eu/en/publications-data/presentation -hivaids-surveillance-europe-2018-2017-data
https://www.ecdc.europa.eu/en/publications-data/ infographic-hiv-late-diagnosis-2017-data
|
[24]
|
Centers for Disease Control and Prevention (CDC); Division of HIV/AIDS Prevention, National Center for HIV/AIDS (2015) Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. HIV Risk Behaviors.
https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html
|
[25]
|
Baggaley, R.F., White, R.G. and Boily, M.-C. (2010) HIV Transmission Risk through Anal Intercourse: Systematic Review, Meta-Analysis and Implications for HIV Prevention. International Journal of Epidemiology, 39, 1048-1063.
https://doi.org/10.1093/ije/dyq057
|
[26]
|
Chi, A. (2019) Pharmacy Essentials for HCV Screening and Management. Clinical Care Options.
https://www.clinicaloptions.com/hepatitis/programs/pharmacy-care/ hcv-screening/pharmacy-hcv-slides
|
[27]
|
Crepaz, N. and Marks, G. (2002) Towards an Understanding of Sexual Risk Behavior in People Living with HIV: A Review of Social, Psychological, and Medical Findings. AIDS, 16, 135-149. https://doi.org/10.1097/00002030-200201250-00002
|
[28]
|
The Health Hazards of Homosexuality (2020) “Gay” (MSM) Sexual Practices & Disease. How Today’s “Gay” Subculture Is Different excerpt from Chapter 6.
http://www.healthhazardsofhomosexuality.info/msm-sex.html
|
[29]
|
Klein, H. (2009) Sexual Orientation, Drug Use Preference during Sex, and HIV Risk Practices and Preferences among Men Who Specifically Seek Unprotected Sex Partners via the Internet. International Journal of Environmental Research and Public Health, 6, 1620-1635. https://doi.org/10.3390/ijerph6051620
|
[30]
|
Lewnard, J.A. and Berrang-Ford, L. (2014) Internet-Based Partner Selection and risk for Unprotected Anal Intercourse in Sexual Encounters among Men Who Have Sex with Men: A Meta-Analysis of Observational Studies. Sexually Transmitted Infections, 90, 290-296. https://doi.org/10.1136/sextrans-2013-051332
|
[31]
|
Basten, M., Heijne, J.C., Geskus, R., Den Daas, C., Kretzschmar, M. and Matser, A. (2018) Sexual Risk Behaviour Trajectories among MSM at Risk for HIV in Amsterdam, the Netherlands. AIDS, 32, 1185-1192.
https://doi.org/10.1097/QAD.0000000000001803
|
[32]
|
Berg, R. (2009) The Effectiveness of Behavioural and Psychosocial HIV/STI Prevention Interventions for MSM in Europe: A Systematic Review. Surveillance, 14, 19430. https://doi.org/10.2807/ese.14.48.19430-en
|
[33]
|
Garner, A. (2019) We Need to Look beyond HIV.
https://www.avert.org/news/alex-garner-%E2%80%98 we-need-look-beyond-hiv%E2%80%99
|
[34]
|
WHO (2020) Why the HIV Epidemic Is Not Over.
https://www.who.int/hiv-aids/latest-news-and-events/why-the-hiv-epidemic-is-not-over
|
[35]
|
Krishnaratne, S., Hensen, B., Cordes, J., Enstone, J. and Hargreaves, J.R. (2016) Interventions to Strengthen the HIV Prevention Cascade: A Systematic Review of Reviews. The Lancet HIV, 3, e307-317.
https://doi.org/10.1016/S2352-3018(16)30038-8
|
[36]
|
Eisinger, R.W., Dieffenbach, C.W. and Fauci, A.S. (2019) HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA, 321, 451-452. https://doi.org/10.1001/jama.2018.21167
|
[37]
|
Vernazza, P., Hirschel, B., Bernasconi, E. and Flepp, M. (2008) Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des médecins suisses, 89, 165-169. (In French) https://doi.org/10.4414/bms.2008.13252
|
[38]
|
Rodger, A.J., Cambiano, V., Bruun, T., et al. (2019) Risk of HIV Transmission through Condomless Sex in Serodifferent Gay Couples with the HIV-Positive Partner Taking Suppressive Antiretroviral Therapy (PARTNER): Final Results of a Multicentre, Prospective, Observational Study. The Lancet, 393, 2428-2438.
https://doi.org/10.1016/S0140-6736(19)30418-0
|
[39]
|
Baral, S., Rao, A., Sullivan, P., Phaswana-Mafuya, N., Diouf, D., Millett, G., Musyoki, H., Geng E. and Mishra, S. (2019) The Disconnect between Individual-Level and Population-Level HIV Prevention Benefits of Antiretroviral Treatment. The Lancet HIV, 6, e632-e638. https://doi.org/10.1016/S2352-3018(19)30226-7
|
[40]
|
Abela, I.A., Scherrer, A.U., Böni, J., et al. (2019) Emergence of Drug Resistance in the Swiss HIV Cohort Study under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients. Clinical Infectious Diseases, 70, 29-303.
https://doi.org/10.1093/cid/ciz178
|
[41]
|
Bosman, A. and Van De Laar, M. (2019) Developing a Reporting System for the Surveillance of HIV Drug Resistance in Europe. ECDC, Stockholm.
|
[42]
|
Le Guillou, A., Pugliese, P., Raffi, F., et al. (2019) Reaching the Second and Third UNAIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary HIV Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort. Clinical Infectious Diseases, pii: ciz800. https://doi.org/10.1093/cid/ciz800
|
[43]
|
Raifman, J., Dean, L.T., Montgomery, M.C., Almonte, A., Arrington-Sanders, R., Stein, M.D., Nunn, A.S., Sosnowy, C.D. and Chan, P.A. (2019) Racial and Ethnic Disparities in HIV Pre-Exposure Prophylaxis Awareness among Men Who Have Sex with Men. AIDS and Behavior, 23, 2706-2709.
https://doi.org/10.1007/s10461-019-02462-3
|
[44]
|
Amon, J.J., Eba, P., Sprague, L., Edwards, O. and Beyrer, C. (2018) Defining Rights-Based Indicators for HIV Epidemic Transition. PLOS Medicine, 15, e1002720. https://doi.org/10.1371/journal.pmed.1002720
|
[45]
|
Ostrow, D.E., Fox, K.J., Chmiel, J.S., Silvestre, A., Visscher, B.R., Vanable, P.A., Jacobson, L.P. and Strathdee, S.A. (2002) Attitudes towards Highly Active Antiretroviral Therapy Are Associated with Sexual Risk Taking among HIV-Infected and Uninfected Homosexual Men. AIDS, 16, 775-780.
https://doi.org/10.1097/00002030-200203290-00013
|
[46]
|
Laporte, A. (2002) A New Decline in Preventive Behaviours among Homosexual Men: The Role of Highly Active Antiretroviral Therapy? Surveillance, 7, 349.
https://doi.org/10.2807/esm.07.02.00349-en
|
[47]
|
Holt, M., Lea, T., Mao, L., et al. (2018) Community-Level Changes in Condom Use and Uptake of HIV Pre-Exposure Prophylaxis by Gay and Bisexual Men in Melbourne and Sydney, Australia: Results of Repeated Behavioural Surveillance in 2013-17. The Lancet HIV, 5, e448-e456.
https://doi.org/10.1016/S2352-3018(18)30072-9
|
[48]
|
Heuker, J., Sonder, G.J., Stolte, I., Geskus, R. and van den Hoek, A. (2012) High HIV Incidence among MSM Prescribed Postexposure Prophylaxis, 2000-2009: Indications for Ongoing Sexual Risk Behaviour. AIDS, 26, 505-512.
https://doi.org/10.1097/QAD.0b013e32834f32d8
|
[49]
|
Bezemer, D., de Wolf, F., Boerlijst, M.C., van Sighem, A., Hollingsworth, T.D., Prins, M., Geskus, R.B., Gras, L., Coutinho, R.A. and Fraser, C. (2008) A Resurgent HIV-1 Epidemic among Men Who Have Sex with Men in the Era of Potent Antiretroviral Therapy. AIDS, 22, 1071-1077.
https://doi.org/10.1097/QAD.0b013e3282fd167c
|
[50]
|
Stolte, I.G., Dukers, N.H., Geskus, R.B., Coutinho, R.A. and de Wit, J.B. (2004) Homosexual Men Change to Risky Sex When Perceiving Less Threat of HIV/AIDS since Availability of Highly Active Antiretroviral Therapy: A Longitudinal Review. AIDS, 18, 303-309. https://doi.org/10.1097/00002030-200401230-00021
|
[51]
|
Jaffe, H.W., Valdiserri, R.O. and De Cock, K.M. (2007) The Reemerging HIV/AIDS Epidemic in Men Who Have Sex with Men. JAMA, 298, 2412-2414.
https://doi.org/10.1001/jama.298.20.2412
|
[52]
|
European Centre for Disease Prevention and Control (2013) STI and HIV Prevention in Men Who Have Sex with Men in Europe. ECDC, Stockholm.
|
[53]
|
Traeger, M., Cornelisse, V., Asselin, J., et al. (2019) Association of HIV Preexposure Prophylaxis with Incidence of Sexually Transmitted Infections among Individuals at High Risk of HIV Infection. JAMA, 321, 1380-1390.
https://doi.org/10.1001/jama.2019.2947
|
[54]
|
Desai, M., Field, N., Grant, R. and McCormack, S. (2017) State of the Art Review: Recent Advances in PrEP for HIV. BMJ, 359, j5011.
https://doi.org/10.1136/bmj.j5011
|
[55]
|
Kramer, S.C., Schmidt, A.J., Berg, R.C., Furegato, M., Hospers, H., Folch, C., Marcus, U. and EMIS Network (2016) Factors Associated with Unprotected Anal Sex with Multiple Non-Steady Partners in the Past 12 Months: Results from the European Men-Who-Have-Sex-With-Men Internet Survey (EMIS 2010). BMC Public Health, 16, Article No. 47. https://doi.org/10.1186/s12889-016-2691-z
|
[56]
|
Nicoll, A. and Hamers, F.F. (2002) Are Trends in HIV, Gonorrhoea, and Syphilis Worsening in Western Europe? BMJ, 324, 1324-1327.
https://doi.org/10.1136/bmj.324.7349.1324
|
[57]
|
European Centre for Disease Prevention and Control (2019) Syphilis and Congenital Syphilis in Europe: A Review of Epidemiological Trends (2007-2018) and Options for Response. ECDC, Stockholm.
|
[58]
|
European Centre for Disease Prevention and Control (2018) Syphilis. ECDC. Annual Epidemiological Report for 2016. ECDC, Stockholm.
|
[59]
|
Robert-Koch-Institute (2015) HIV, Hepatitis B und C bei infizierenden Drogengebrauchenden in Deutschland-Ergebnisse der DRUCK-Studie des RKI. Epidemiologisches Bulletin, 22, 191-197. (In German)
|
[60]
|
Centers for Disease Control and Prevention (CDC) (2011) Sexual Transmission of Hepatitis C Virus among HIV-Infected Men Who Have Sex with Men—New York City, 2005-2010. Morbidity and Mortality Weekly Report, 60, 945-950.
|
[61]
|
CDC 24/7 (2017) Syphilis. Sexually Transmitted Disease Surveillance 2017.
https://www.cdc.gov/std/stats17/syphilis.htm
|
[62]
|
Robert-Koch-Institute (RKI) (2018) Syphilis in Deutschland im Jahr 2017; Anstieg von Syphilis-Infektionen bei Männern, die Sex mit Männern haben, setzt sich weiter fort. Epidemiologisches Bulletin, 46, 493-504. (In German)
|
[63]
|
Urbanus, A.T., van Houdt, R., van de Laar, T.J. and Coutinho, R.A. (2009) Viral Hepatitis among Men Who Have Sex with Men, Epidemiology and Public Health Consequences. Surveillance, 14, 19421. https://doi.org/10.2807/ese.14.47.19421-en
|
[64]
|
Popper, K. (2003) Open Society and Their Enemies. 8. Auflage J.C.B. Mohr Paul Siebeck, Tübingen, ISB 3-16-148069-4. (In German)
|
[65]
|
Frieden, T.R., Das-Douglas, M., Kellerman, S.E. and Henning, K.J. (2005) Applying Public Health Principles to the HIV Epidemic. The New England Journal of Medicine, 353, 2397-2402. https://doi.org/10.1056/NEJMsb053133
|
[66]
|
Bracchi, M., Stuart, D., Castles, R., Khoo, S., Back, D. and Boffito, M. (2015) Increasing Use of “Party Drugs” in People Living with HIV on Antiretrovirals: A Concern for Patient Safety. AIDS, 29, 1585-1592.
https://doi.org/10.1097/QAD.0000000000000786
|
[67]
|
Giorgetti, R., Tagliabracci, A., Schifano, F., Zaami, S., Marinelli, E. and Busardò, F.P. (2017) When “Chems” Meet Sex: A Rising Phenomenon Called “ChemSex”. Current Neuropharmacology, 15, 762-770.
https://doi.org/10.2174/1570159X15666161117151148
|
[68]
|
Schwetz, T.A., Calder, T., Rosenthal, E., Kattakuzhy, S. and Fauci, A.S. (2019) Opioids and Infectious Diseases: A Converging Public Health Crisis. The Journal of Infectious Diseases, 220, 346-349. https://doi.org/10.1093/infdis/jiz133
|
[69]
|
Pakianathan, M., Whittaker, W., Lee, M.J., Avery, J., Green, S., Nathan, B. and Hegazit, A. (2018) Chemsex and New HIV Diagnosis in Gay, Bisexual and Other Men Who Have Sex with Men Attending Sexual Health Clinics. HIV Medicine.
https://doi.org/10.1111/hiv.12629
|
[70]
|
Pufall, E.L., Kall, M., Shahmanesh, M., Nardone, A., Gilson, R., Delpech, V. and Ward, H. (2018) Sexualized Drug Use (“Chemsex”) and High-Risk Sexual Behaviours in HIV-Positive Men Who Have Sex with Men. HIV Medicine, 19, 261-270.
https://doi.org/10.1111/hiv.12574
|
[71]
|
González-Baeza, A., Dolengevich-Segal, H., Pérez-Valero, I., et al. (2018) Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study. AIDS Patient Care STDS, 32, 112-118.
https://doi.org/10.1089/apc.2017.0263
|
[72]
|
Bouvin-Pley, M., Beretta, M., Moreau, A., et al. (2019) Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic. Journal of Virology, 93, pii: e01171-18.
https://doi.org/10.1128/JVI.01171-18
|
[73]
|
Wirden, M., De Oliveira, F., Bouvier-Alias, M., et al. (2019) New HIV-1 Circulating Recombinant form 94: From Phylogenetic Detection of a Large Transmission Cluster to Prevention in the Age of Geosocial-Networking Apps in France, 2013 to 2017. Surveillance, 24, 1800658. https://doi.org/10.2807/1560-7917.ES.2019.24.39.1800658
|
[74]
|
Delgado, E., Benito, S., Montero, V., et al. (2019) Diverse Large HIV-1 Non-Subtype B Clusters Are Spreading among Men Who Have Sex with Men in Spain. Frontiers in Microbiology, 10, 655. https://doi.org/10.3389/fmicb.2019.00655
|
[75]
|
Patiño-Galindo, J.á., Domínguez, F., Cuevas, M.T., et al. (2018) Genome-Scale Analysis of Evolutionary Rate and Selection in a Fast-Expanding Spanish Cluster of HIV-1 Subtype F1. Infection, Genetics and Evolution, 66, 43-47.
https://doi.org/10.1016/j.meegid.2018.09.008
|
[76]
|
Kusejko, N., Bachmann, N., Chaudron, S.E., et al. (2019) A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 with Coinfections, Non-Communicable and Opportunistic Diseases. The Journal of Infectious Diseases, 220, 244-253.
https://doi.org/10.1093/infdis/jiz093
|
[77]
|
Stevens, O., Moncrieff, M. and Gafos, M. (2019) Chemsex-Related Drug Use and Its Association with Health Outcomes in Men Who Have Sex with Men: A Cross-Sectional Analysis of Antidote Clinic Service Data. Sexually Transmitted Infections, pii: sextrans-2019-054040. https://doi.org/10.1136/sextrans-2019-054040
|
[78]
|
Beck U. Risk Society (1992) Towards a New Modernity. SAGE Publications Ltd., London.
|
[79]
|
UNAIDS Reference Group on HIV and Human Rights (2009) Recommendations Brief to Michel Sidibe, UNAIDS Executive Director.
http://data.unaids.org/pub/basedocument/2009/20090302_hrrefgroupsidibebriefeng_en.pdf
|
[80]
|
Long, E.F., Brandeau, M.L. and Owens, D.K. (2010) The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States. Annals of Internal Medicine, 153, 778-789.
https://doi.org/10.7326/0003-4819-153-12-201012210-00004
|
[81]
|
De Francesco, D., Verboeket, S.O., Underwood, J., et al. (2018) Patterns of Co-Occurring Comorbidities in People Living with HIV. Open Forum Infectious Diseases, 5, ofy272. https://doi.org/10.1093/ofid/ofy272
|
[82]
|
Glass, R.I. (2014) HIV/AIDS and Noncommunicable Disease Comorbidities: Emerging Research Priorities. JAIDS Journal of Acquired Immune Deficiency Syndromes, 67, S1. https://doi.org/10.1097/QAI.0000000000000266
|
[83]
|
Jin, F., Vajdic, C.M., Law, M., Amin, J., van Leeuwen, M., McGregor, S., Poynten, I.M., Templeton, D.J. and Grulich, A.E. (2019) Incidence and Time Trends of Anal Cancer among People Living with HIV in Australia. AIDS, 33, 1361-1368.
https://doi.org/10.1097/QAD.0000000000002218
|
[84]
|
Bosh, K.A., Crepaz, N., Dong, X., Lyss, S., Mendoza, M. and Mitsch, A.J. (2019) Opioid Overdose Deaths among Persons with HIV Infection, United States, 2011-2015. Conference on Retroviruses and Opportunistic Infections, 4-7 March 2019, Seattle, Abstract Number: 147.
http://www.croiconference.org/sessions/opioid-overdose-deaths- among-persons-hiv-infection-united-states-2011-2015
|
[85]
|
HIV.gov (2019) Other Health Issues of Special Concern for People Living with HIV.
https://www.hiv.gov/hiv-basics/staying-in-hiv-care/other-related-health-issues/other- health-issues-of-special-concern-for-people-living-with-hiv
|
[86]
|
Thakur, K.T., Boubour, A., Saylor, D., Das, M., Bearden, D. and Birbeck, G.L. (2019) Global HIV Neurology: A Comprehensive Review. AIDS, 33, 163-184.
https://doi.org/10.1097/QAD.0000000000001796
|
[87]
|
Rosenthal, J. and Tyor, W.R. (2019) Aging, Comorbidities, and the Importance of Finding Biomarkers for HIV-Associated Neurocognitive Disorders. Journal of NeuroVirology, 25, 673-685. https://doi.org/10.1007/s13365-019-00735-0
|
[88]
|
Azoulay, é., de Castro, N. and Barbier, F. (2019) Critically Ill Patients with HIV: 40 Years Later. Chest, pii: S0012-3692(19)31453-9.
https://doi.org/10.1016/j.chest.2019.08.002
|
[89]
|
Petruzziello, A., Loquercio, G., Sabatino, R., et al. (2019) Prevalence of Hepatitis C Virus Genotypes in Nine Selected European Countries: A Systematic Review. Journal of Clinical Laboratory Analysis, 33, e22876. https://doi.org/10.1002/jcla.22876
|
[90]
|
Ramière, C., Charre, C., Miailhes, P., et al. (2019) Patterns of HCV Transmission in HIV-Infected and HIV-Negative Men Having Sex with Men. Clinical Infectious Diseases, 69, 2127-2135. https://doi.org/10.1093/cid/ciz160
|
[91]
|
Charre, C., Cotte, L., Kramer, R., Miailhes, P., Godinot, M., Koffi, J., Scholtès, C. and Ramière, C. (2018) Hepatitis C Virus Spread from HIV-Positive to HIV-Negative Men Who Have Sex with Men. PLoS ONE, 13, e0190340.
https://doi.org/10.1371/journal.pone.0190340
|
[92]
|
Lerner, A.M., Eisinger, R.W. and Fauci, A.S. (2020) Comorbidities in Persons with HIV: The Lingering Challenge. JAMA, 323, 19-20.
https://doi.org/10.1001/jama.2019.19775
|
[93]
|
Schroeder, S.E., Higgs, P., Winter, R., Brown, G., Pedrana, A., Hellard, M., Doyle, J. and Stoové, M. (2019) Hepatitis C Risk Perceptions and Attitudes towards Reinfection among HIV-Diagnosed Gay and Bisexual Men in Melbourne, Australia. Journal of the International AIDS Society, 22, e25288. https://doi.org/10.1002/jia2.25288
|
[94]
|
van de Laar, T.J., Matthews, G.V., Prins, M. and Danta, M. (2010) Acute Hepatitis C in HIV-Infected Men Who Have Sex with Men: An Emerging Sexually Transmitted Infection. AIDS, 24, 1799-1812. https://doi.org/10.1097/QAD.0b013e32833c11a5
|
[95]
|
AASLD, IDSA, (2020) HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Last Updated: November 6, 2019.
https://www.hcvguidelines.org/sites/default/files/full-guidance- pdf/200206_HCVGuidance_November_06_2019_a.pdf
|
[96]
|
Conference Reports of NATAP (2016) Hepatitis C Virus Reinfection Incidence and Outcomes among HIV-Positive MSM in Western Europe. The International Liver CongressTM EASL European Association for the Study of the Liver, Barcelona, 13-17 April 2016. http://www.natap.org/2016/EASL/EASL_12.htm
|
[97]
|
Lacombe, K. (2019) Lessons from France on Implementing HCV Treatment as Prevention: Whom Should We Treat and How?
https://www.clinicaloptions.com/hepatitis/programs/hcv-treatment -as-prevention/clinicalthought
|
[98]
|
Popping, S., Cento, V., García, F., Ceccherini-Silberstein, F., Seguin-Devaux, C., van de AMC Vijver, D. and Boucher Ch, A. (2018) The Need for a European Hepatitis C Programme Monitoring Resistance to Direct-Acting Antiviral Agents in Real Life to Eliminate Hepatitis C. Journal of Virus Eradication, 4, 179-181.
|
[99]
|
Sweeney, S., Ward, Z., Platt, L., et al. (2019) Evaluating the Cost-Effectiveness of Existing Needle and Syringe Programmes in Preventing Hepatitis C Transmission in People Who Inject Drugs. Addiction, 114, 560-570.
https://doi.org/10.1111/add.14519
|
[100]
|
Pericàs, J.M., Bromberg, D.J., Ocampo, D., Schatz, E., Wawer, I., Wysocki, P., Safreed-Harmon, K. and Lazarus, J.V. (2019) Hepatitis C Services at Harm Reduction Centres in the European Union: A 28-Country Survey. Harm Reduction Journal, 16, 20. https://doi.org/10.1186/s12954-019-0290-x
|
[101]
|
Trickey, A., Fraser, H., Lim, A.G., et al. (2019) The Contribution of Injection Drug Use to Hepatitis C Virus Transmission Globally, Regionally, and at Country Level: A Modelling Study. The Lancet Gastroenterology and Hepatology, 4, 435-444.
https://doi.org/10.1016/S2468-1253(19)30085-8
|
[102]
|
Li, J., Gilmour, S., Zhang, H., Koyanagi, A. and Shibuya, K. (2012) The Epidemiological Impact and Cost Effectiveness of HIV Testing, Antiretroviral Treatment and Harm Reduction Programs. AIDS, 26, 2069-2078.
https://doi.org/10.1097/QAD.0b013e3283574e54
|
[103]
|
Eaton, E.F., Tamhane, A., Saag, M., Mugavero, M.J. and Kilgore, M.L. (2016) Cost Consideration in the Current Antiretroviral Era. AIDS, 30, 2115-2119.
https://doi.org/10.1097/QAD.0000000000001120
|
[104]
|
Linderhill, K. (2012) Paying for Prevention: Challenges to Health Insurance Coverage for Medical HIV Prevention in the United States. The American Journal of Law & Medicine, 38, 607-666. https://doi.org/10.1177/009885881203800402
|
[105]
|
Krebs, E., Zang, X., Enns, B., et al. (2019) The Impact of Localized Implementation: Determining the Cost-Effectiveness of HIV Prevention and Care Interventions across Six United States Cities. AIDS, 34, 447-458.
https://doi.org/10.1097/QAD.0000000000002455
|
[106]
|
Centers for Disease Control and Prevention (2011) Sexual Transmission of Hepatitis C Virus among HIV-Infected Men Who Have Sex with Men—New York City, 2005-2010. MMWR, 60, 945-950.
|
[107]
|
Pradat, P., Huleux, T., Raffi, F., et al. (2018) Incidence of New Hepatitis C Virus Infection Is Still Increasing in French MSM Living with HIV. AIDS, 32, 1077-1082.
https://doi.org/10.1097/QAD.0000000000001789
|
[108]
|
Martin, T.C., Martin, N.K., Hickman, M., Vickerman, P., Page, E.E., Everett, R., Gazzard, B.G. and Nelson, M. (2013) Hepatitis C Virus Reinfection Incidence and Treatment Outcome among HIV-Positive MSM. AIDS, 27, 2551-2557.
https://doi.org/10.1097/QAD.0b013e32836381cc
|
[109]
|
Berenguer, J., Gil-Martin, á., Jarrin, I., et al. (2019) Reinfection by Hepatitis C Virus Following Effective All-Oral Direct-Acting Antiviral Drug Therapy in HIV/Hepatitis C Virus Coinfected Individuals. AIDS, 33, 685-689.
https://doi.org/10.1097/QAD.0000000000002103
|
[110]
|
Hajarizadeh, B., Cunningham, E.B., Valerio, H., et al. (2019) Hepatitis C Reinfection after Successful Antiviral Treatment among People Who Inject Drugs: A Meta-Analysis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2019.11.012
|
[111]
|
AVERT (2019) HIV Prevention Programmes Overview.
https://www.avert.org/professionals/hiv-programming/prevention
|
[112]
|
Bhatia, T., Enoch, J., Khan, M., Mathewson, S., Heymann, D., Hayes, R. and Dar, O. (2019) Setting Targets for HIV/AIDS—What Lessons Can Be Learned from Other Disease Control Programmes? PLOS Medicine, 16, e1002735.
https://doi.org/10.1371/journal.pmed.1002735
|
[113]
|
Fauci, A.S., Redfield, R.R., Sigounas, G., Weahkee, M.D. and Giroir, B.P. (2019) Ending the HIV Epidemic: A Plan for the United States. JAMA, 321, 844-845.
https://doi.org/10.1001/jama.2019.1343
|
[114]
|
Brown, T. and Peerapatanapokin, W. (2019) Evolving HIV Epidemics: The Urgent Need to Refocus on Populations with Risk. Current Opinion in HIV and AIDS, 14, 337-353. https://doi.org/10.1097/COH.0000000000000571
|
[115]
|
Mayer, K.H. and Allan-Blitz, L.-T. (2019) Similar, But Different: Drivers of the Disproportionate HIV and Sexually Transmitted Infection Burden of Key Populations. Journal of the International AIDS Society, 22, e25344.
https://doi.org/10.1002/jia2.25344
|
[116]
|
Verhofstede, C., Mortier, V., Dauwe, K., et al. (2019) Exploring HIV-1 Transmission Dynamics by Combining Phylogenetic Analysis and Infection Timing. Viruses, 11, pii: E 1096. https://doi.org/10.3390/v11121096
|
[117]
|
HIV.gov. (2019) National HIV Testing Day. Results of Partnership Work at National HIV Testing Day 2019 Show That Local Engagement in HIV Testing Matters.
https://www.hiv.gov/topics/hivtestingday
https://www.hiv.gov/blog/recapping-national-hiv-testing-day-2019
|
[118]
|
Ghimire, S., Hallett, J., Gray, C., Lobo, R. and Crawford, G. (2019) What Works? Prevention and Control of Sexually Transmitted Infections and Blood-Borne Viruses in Migrants from Sub-Saharan Africa, Northeast Asia and Southeast Asia Living in High-Income Countries: A Systematic Review. International Journal of Environmental Research and Public Health, 16, E1287.
https://doi.org/10.3390/ijerph16071287
|
[119]
|
Hachfeld, A., Darling, K., Calmy, A., et al. (2019) Why Do Sub-Saharan Africans Present Late for HIV Care in Switzerland? HIV Medicine, 20, 418-423.
https://doi.org/10.1111/hiv.12727
|
[120]
|
Zhu, W., Bazzi, S.A. and Bazzi, A.R. (2019) Behavioral Changes Following HIV Seroconversion during the Historical Expansion of HIV Treatment in the United States. AIDS, 33, 113-121. https://doi.org/10.1097/QAD.0000000000002048
|
[121]
|
Wu, Z., Tang, Z., Mao, Y., et al. (2017) Testing and Linkage to HIV Care in China: A Cluster-Randomised Trial. The Lancet HIV, 4, e555-e565.
https://doi.org/10.1016/S2352-3018(17)30131-5
|
[122]
|
National Institute of Allergy and Infectious Diseases (NIAID, USA) (2019) Connection to HIV Care Helps Hardly Reached US Populations Suppress the Virus. NIH-Funded Study Evaluated Strategies to Identify and Support Men Who Have Sex with Men and Transgender Women with Unsuppressed HIV.
https://www.niaid.nih.gov/news-events/connection-hiv-care-helps- hardly-reached-us-populations-suppress-virus
|
[123]
|
Zang, X., Krebs, E., Min, J.E., et al. (2020) Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities. Medical Decision Making, 40, 3-16. https://doi.org/10.1177/0272989X19889356
|
[124]
|
Lockard, A., Rosenberg, E.S., Sullivan, P.S., Kelley, C.F., Serota, D.P., Rolle, C.M., Luisi, N., Pingel, E. and Siegler, A.J. (2019) Contrasting Self-Perceived Need and Guideline-Based Indication for HIV Pre-Exposure Prophylaxis among Young, Black Men Who Have Sex with Men Offered Pre-Exposure Prophylaxis in Atlanta, Georgia. AIDS Patient Care and STDs, 33, 112-119.
https://doi.org/10.1089/apc.2018.0135
|
[125]
|
Ong, J.J., Baggaley, R.C., Wi, T.E., et al. (2019) Global Epidemiologic Characteristics of Sexually Transmitted Infections among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection a Systematic Review and Meta-Analysis. JAMA Network Open, 2, e1917134.
https://doi.org/10.1001/jamanetworkopen.2019.17134
|
[126]
|
Medina-Perucha, L., Family, H., Scott, J., et al. (2019). Factors Associated with Sexual Risks and Risk of STIs, HIV and Other Blood-Borne Viruses among Women Using Heroin and Other Drugs: A Systematic Literature Review. AIDS and Behavior, 23, 222-251. https://doi.org/10.1007/s10461-018-2238-7
|
[127]
|
HIV.gov. (2019) What Is “Ending the HIV Epidemic: A Plan for America”?
https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview
|